Suppr超能文献

一个适用于天然化合物库探索的抗生物膜检测平台。

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries.

作者信息

Skogman Malena E, Vuorela Pia M, Fallarero Adyary

机构信息

Pharmaceutical Design and Discovery (PharmDD), Faculty of Pharmacy, University of Helsinki.

Pharmaceutical Design and Discovery (PharmDD), Faculty of Pharmacy, University of Helsinki;

出版信息

J Vis Exp. 2016 Dec 27(118):54829. doi: 10.3791/54829.

Abstract

Biofilms are regarded as one of the most challenging topics of modern biomedicine, and they are potentially responsible for over 80% of antibiotic-tolerant infections. Biofilms have displayed an exceptionally high tolerance for chemotherapy, which is thought to be multifactorial. For instance, the matrix provides a physical barrier that decreases the penetration of antibiotics into the biofilm. Also, cells within the biofilms are phenotypically diverse. Likely, biofilm resilience arises from a combination of these and other, yet unknown, mechanisms. All of the currently existing antibiotics have been developed against single-cells (planktonic) bacteria. Therefore, so far, a very limited repertoire of molecules exists that can selectively act on mature biofilms. This situation has driven a progressive paradigm shift in drug discovery, in which searching for anti-biofilms has been urged to occupy a more prominent place. An additional challenge is that there are a very limited number of standardized methods for biofilm research, especially those that can be used for large-throughput screening of chemical libraries. Here, an experimental anti-biofilm platform for chemical screening is presented. It uses three assays to measure biofilm viability (with resazurin staining), total biomass (with crystal violet staining), and biofilm matrix (using a wheat germ agglutinin, WGA-fluorescence-based staining of the poly-N-acetyl-glucosamine, PNAG, fraction). All the assays were developed using Staphylococcus aureus as the model bacteria. Examples of how the platform can be used for primary screening as well as for functional characterization of identified anti-biofilm hits are presented. This experimental sequence further allows for the classification of the hits based upon the measured end-points. It also provides information on their mode of action, especially on long-term versus short-term chemotherapeutic effects. Thus, it is very advantageous for the quick identification of high-quality hit compounds that can serve as starting points for various biomedical applications.

摘要

生物膜被视为现代生物医学中最具挑战性的课题之一,它们可能导致超过80%的耐抗生素感染。生物膜对化疗表现出极高的耐受性,其原因被认为是多方面的。例如,生物膜基质提供了一个物理屏障,降低了抗生素进入生物膜的渗透率。此外,生物膜内的细胞在表型上具有多样性。生物膜的恢复力可能源于这些机制以及其他未知机制的综合作用。目前所有现有的抗生素都是针对单细胞(浮游)细菌开发的。因此,到目前为止,能够选择性作用于成熟生物膜的分子种类非常有限。这种情况推动了药物研发领域的渐进式范式转变,促使抗生物膜研究在其中占据更突出的地位。另一个挑战是,用于生物膜研究的标准化方法数量非常有限,尤其是那些可用于化学文库高通量筛选的方法。在此,我们展示了一个用于化学筛选的实验性抗生物膜平台。它使用三种检测方法来测量生物膜活力(用刃天青染色)、总生物量(用结晶紫染色)以及生物膜基质(使用基于小麦胚芽凝集素、WGA的聚-N-乙酰葡糖胺、PNAG部分的荧光染色)。所有检测方法均以金黄色葡萄球菌作为模式细菌开发而成。文中展示了该平台如何用于初步筛选以及对已鉴定的抗生物膜活性物质进行功能表征的示例。这个实验序列还能根据测量的终点对活性物质进行分类。它还提供了有关其作用模式的信息,特别是关于长期与短期化疗效果的信息。因此,对于快速鉴定可作为各种生物医学应用起点的高质量活性化合物非常有利。

相似文献

引用本文的文献

本文引用的文献

3
The Challenging World of Biofilm Physiology.生物膜生理学的挑战世界。
Adv Microb Physiol. 2015;67:235-92. doi: 10.1016/bs.ampbs.2015.09.003. Epub 2015 Oct 27.
8
The in vivo biofilm.体内生物膜。
Trends Microbiol. 2013 Sep;21(9):466-74. doi: 10.1016/j.tim.2013.06.002. Epub 2013 Jul 2.
10
Natural products: a continuing source of novel drug leads.天然产物:新型药物先导物的持续来源。
Biochim Biophys Acta. 2013 Jun;1830(6):3670-95. doi: 10.1016/j.bbagen.2013.02.008. Epub 2013 Feb 18.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验